Table 2.
The clinicopathological factors of NSCLC and the association with KLK11 levels
| Factors | n | KLk11 (ng/ml) | P- value |
|---|---|---|---|
| Age, year | 0.569 | ||
| ≥60 | 62 | 2.07 ± 0.77 | |
| <60 | 76 | 2.12 ± 0.66 | |
| Gender | 0.505 | ||
| Male | 80 | 2.16 ± 0.82 | |
| Female | 58 | 1.99 ± 0.53 | |
| Histology | 0.713 | ||
| AC | 78 | 2.05 ± 0.85 | |
| SCC | 60 | 2.01 ± 0.53 | |
| TNM stage | 0.000 | ||
| I–II | 88 | 2.51 ± 0.61 | |
| III–IV | 50 | 1.76 ± 0.63 | |
| Lymph node metastases | 0.000 | ||
| Absent | 68 | 2.41 ± 0.64 | |
| Present | 70 | 1.65 ± 0.57 | |
| Distant metastases | 0.000 | ||
| Absent | 98 | 2.38 ± 0.59 | |
| Present | 40 | 1.89 ± 0.71 |
AC adenocarcinoma, SCC squamous cell carcinoma